2026-07-282026-07-272026-07-242026-07-232026-07-222026-07-212026-07-202026-07-172026-07-162026-07-152026-07-142026-07-102026-06-292026-06-192026-06-182026-06-172026-06-162026-06-152026-06-122026-06-112026-06-102026-06-092026-06-082026-06-052026-06-042026-06-032026-06-022026-06-012026-05-302026-05-292026-05-282026-05-272026-05-252026-05-222026-05-212026-05-202026-05-192026-05-182026-05-152026-05-11
Stock-market dispatch — 2026-06-16
Auto-generated by the daily research routine (headless Pi run). Summary of what changed in the wiki today; the wiki is the truth. Research output, not advice — brain never trades.
Top of mind
Broad risk-on rally in the book; the day's research payload is a dual-sourced private-credit chain. Memory/semis/uranium/space ripped — MU +10.84% to $1,088 (near 52w high $1,097) into its June 24 gate, SPCX +19.6%, ARM +8.3%, TLN +7.1%, NXE +7.0%, UEC/RKLB/ASTS/CCJ +6–7% (CCJ $107), DNN +8.2%, TSM +4.1%, LRCX +6.0%, NVDA +3.5%, CEG +3.4%; LIN sat out (−0.4%, defensive). The sharpest research update: the ai-capex-derate-to-private-credit-contagion hypothesis got dual-sourced — PIMCO CIO dan-ivascyn (Compound & Friends) articulating "AI feasting on old-economy businesses… higher realized losses independent of the economy" plus a same-day UBS note quantifying 25–35% of private credit as AI-disruption-exposed and "not priced in" (loans near par while equities/bankruptcy data diverge). That cross-links the agentic-ai-seat-erosion-to-saas-rerate chain through credit (same cluster, credit vs equity) and is flagged the #1 /explore-chain candidate. Helium added a demand-leg lock-in (Samsung/SK Hynix long-term contracts with LIN/APD, Apr 11). Breadth steered to thin verticals (healthcare #8, financials #9). 0 live-feedback flags (<−10% sector-excess); 0 calibrations — a corroboration/strengthening day.
Strongest-conviction buys
Ranked shortlist from step 4c — chains, not advice. Prices 2026-06-16 (twelvedata, 59/63; 4 expected non-fetchables ASE/BESI/GNKG/HXSCL carry prior).
| # | Ticker | Causal chain (mechanism) | Conviction | Valuation vs base | Fundamentals (one line) | Next catalyst |
|---|---|---|---|---|---|---|
| 1 | LIN | ras-laffan-halt-to-lin-helium-pricing-power | High (0.78) | At base — $521.48, ~1% off 52w hi | High-margin industrial gas, net-cash, 85–90% contracted; flat while book ripped = defensive quality; helium excluded from guide | APD Q3 late-July; late-summer restart (un-dated falsifier) |
| 2 | CCJ | kazatomprom-supply-cut-to-western-uranium-premium + ai-capex-to-power-and-materials-cascade | Medium-high (0.72) | Yes — $107.02 +6.0%, −21% from hi | Q1 $845M rev/$509M EBITDA, term $90 (14-yr high), ~1B lbs uncovered | Utility contracting; FERC Jun 30 (indirect) |
| 3 | MU | hbm-cowos-as-binding-bottleneck + helium-cliff-to-hbm-supply-crunch | Medium-high (0.68) | Narrowed/priced — $1,088 +10.84% to near 52w hi | HBM sold out several qtrs; GM 74.9% actual → ~81% Q3 guide; ~11× fwd | Q3 FY2026 earnings Jun 24 (now priced for a beat) |
| 4 | WST | glp1-injectable-supply-chain-bottleneck | Medium-high (0.66) | Marginal — $331.43, −2% from hi (held up) | GLP-1 ~18% of sales; HVP devices +29%; per-unit consumable, price-agnostic | 503B comment-close Jun 29; Medicare $50 demo Jul 1 |
| 5 | TSM | hbm-cowos-as-binding-bottleneck | Medium-high (0.62) | Marginal — $441.40 +4.1%, −2% from hi | CoWoS/HBM binding bottleneck; 50%+ GM, backlog | CoWoS adds; HBM4 ramp |
Watchlist
| Ticker | Thesis | Conviction | Price | Undervalued vs base? | Next catalyst |
|---|---|---|---|---|---|
| LIN | ras-laffan-halt-to-lin-helium-pricing-power | High | $521.48 | At base | APD Q3 late-July |
| CCJ | kazatomprom-supply-cut-to-western-uranium-premium | Medium-high | $107.02 ↑6% | Yes | Contracting; India 2027 |
| MU | hbm-cowos-as-binding-bottleneck | Medium-high | $1,088 ↑11% | Narrowed/priced | Q3 earnings Jun 24 |
| CEG | pjm-capacity-prices-to-nuclear-premium | Medium | $262.35 ↑3% | Dislocated (−36% from hi) | FERC RM26-4 by Jun 30; Calpine lockup Jun 30 |
| WST | glp1-injectable-supply-chain-bottleneck | Medium-high | $331.43 | Marginal | 503B Jun 29; Medicare Jul 1 |
| CF | hormuz-nitrogen-supply-shock-to-cf-risk-premium | Medium | $106.90 ↓2% | Yes | H2 nitrogen season |
| PWR | pwr-transformer-moat-to-eps-doubling | Medium | $724.35 ↑2% | Marginal (near hi) | FERC Jun 30 |
| MP | drone-warfare-demand-to-mp-hree-rerate | Medium | $58.26 | Yes (−42% from hi) | HREE circuit H2'26 |
| NOW | agentic-ai-seat-erosion-to-saas-rerate | Medium (winner-long) | $104.15 ↑2% | Yes (−51% from hi) | Q2 FY2026 earnings |
| UNP/NSC | up-nsc-transcontinental-merger-to-pricing-power | Medium | $267.32 / $310.28 | Merger-arb | STB supplemental Jul 27 |
Undervalued candidates (today)
- CCJ $107.02 — term $90 (14-yr high), −21% from hi even after +6%; uncovered-requirements leg holds.
- CEG $262.35 — still −36% from hi; FERC RM26-4 §205-path-stays-open reinforces the front-of-meter read into Jun 30.
- NOW $104.15 — −51% from hi, reframed relative-winner; live sector-excess only −3.7% (theme-wide, not NOW-specific).
New chains to investigate (hypothesis-stage)
- ai-capex-derate-to-private-credit-contagion — ARCC/FSK/OWL/BX/ARES/APO. Now dual-sourced (Ivascyn/PIMCO primary + UBS quantification) → priority high; gap is the per-name exposure cut (short high-software-exposure tech-heavy BDCs / long low-exposure managers). → /explore-chain to graduate into a mechanism.
- Carryover: el-nino-drought-to-water-infrastructure-capex (XYL/AWK), humanoid-actuator-magnet-demand-to-us-ree-stack (USAR $23 +4.7%/MP/TSLA), talen-energy-replacement-cost-pjm-scarcity (TLN $386 +7%), mgm-diller-bid-floor-japan-dubai (MGM $48.62 −0.7%).
New theses (now active)
- None promoted — corroboration/strengthening-heavy day. The day's strongest new chain (private-credit contagion) is held a high-priority hypothesis pending /explore-chain (its tradeable-endpoint step is the un-cited per-name gap).
Updated theses (existing active)
- ras-laffan-halt-to-lin-helium-pricing-power (LIN) — demand-leg lock-in: Samsung/SK Hynix signed long-term helium contracts with LIN/APD (Apr 11); restart still un-dated, shortage up to 5yr. Step 2 strengthened; signal re-dated.
- hbm-cowos-as-binding-bottleneck (MU/TSM) — pre-MU-earnings: sold out several qtrs, widest deficit since 2011 (HBM 5.1%), GM 74.9% actual vs ~81% Q3 guide reconciled (expansion, not contradiction). MU +10.8% melt-up = priced for a beat into Jun 24.
- pjm-capacity-prices-to-nuclear-premium (CEG/TLN) — FERC RM26-4 order by Jun 30 (doc type unspecified); §205 co-location filings continue → keeps CEG's front-of-meter path open regardless of the rule's form.
- glp1-injectable-supply-chain-bottleneck (WST/STVN) — LLY/NVO list-price cuts to $149–350 (MFN/TrumpRx) + Medicare Bridge Jul 1 sharpen the device-over-manufacturer split (per-unit suppliers price-agnostic).
- supply-shock-inflation-persistence / p-and-c-insurer-float-income-rate-regime — rate-cut expectations reversed (~3 cuts → possible hike) on inflation reaccel; the curve now pricing the persistence; higher-for-longer extends the insurer-float window.
Contradicted / weakened
- None. 0 calibrations; 0 live-feedback flags (<−10% sector-excess). The private-credit chain was strengthened (dual-sourced), not contradicted.
Open questions worth a human's eye
- Private-credit: which named BDCs carry the most AI-disrupted-SaaS loan exposure (the /explore-chain gap that converts the hypothesis to a mechanism)?
- MU Jun 24: after a +10.8% melt-up to near 52w high, is the print now priced for perfection (DRAM inventory build = the bear tell)?
- FERC Jun 30: NOPR (defers co-location finality) or a substantive rule?
- Biotech rotation (XBI +55% since Jun 1) — does it become a tradeable chain or stay consensus momentum?
What I looked at
- Run status: full headless Pi daily run (steps 0.5–7) completed synchronously; paced 63-ticker price fetch ran to completion in-turn.
- Macro buckets: Healthcare #8, Financials/rate-regime #9 — both thin verticals per 2a (ai-infrastructure 50%, ⚠ over).
- Ingestion veins (0.5–0.7): podcast-ingest 2 transcripts (Compound/Ivascyn-PIMCO, ILtB/Kareem-Amin; Bg2 failed — AssemblyAI 400, 4th consecutive, logged); earnings-ingest 0 (no-op, MU reports Jun 24); feed-ingest 0 (SemiAnalysis all-ingested; Construction Physics off-scope/roundups).
- Step-1 refreshes: 4 autoresearch (HBM/MU, helium/LIN, FERC/nuclear, private-credit). Step-2 buckets: 2 (healthcare, financials). prospect-chains: 0 drafted (well-connected wiki; refinements not novel).
- Sources promoted: 7; ingested: 7 → new pages: 1 person (dan-ivascyn); 6 mechanisms/concepts strengthened; extract-mechanisms 0 new (private-credit chain held as hypothesis).
- Valuation snapshots: 59/63 tickers (twelvedata, 0 rate errors); anchor concepts refreshed (helium/LIN, hbm/MU, nuclear/CCJ-CEG-BWXT-UEC); others carry prior (prices folded into watchlist + signals).
- Live feedback (4e):
performance-2026-06-16(21 positions) — 0 flagged <−10% sector-excess; CEG recovered to −4.8% (from −10.7%). - Paper ledger (4d): weekly mark not due (last 06-11). Calibrations: 0. Conviction buys ranked: 5. New hypothesis chains opened: 0 (1 carryover hardened → /explore-chain).
- Signal feed: full active/armed set, gated ≥0.4 — see step 7 (Supabase sync performed by the wrapper, not this run).